Injective (INJ) is currently priced at $2.93, experiencing a minor 24-hour decline of 0.61%. The daily trading range has been tight, with a high of $3.04 and a low of $2.90, indicating limited volatility in the short term.

Trading volume stands at approximately $41.4 million, representing 14.17% of the market capitalization, which suggests healthy trading activity. The hourly moving averages show a bearish trend, particularly the 8 SMA at $2.98, indicating a downward shift, while longer-term averages like the 144 SMA at $2.85 demonstrate some potential support.

The 1-hour RSI is notably low at 23, suggesting the asset is oversold in the very short term. Conversely, the 7-day RSI at 56 indicates a neutral stance, reflecting some upward momentum over the past week, with a price change of 1.62%.

Despite recent fluctuations, the 14-day price change shows a significant decline of 4.51%, highlighting a bearish trend in the medium term. However, the 30-day price change is nearly flat at -0.20%, indicating potential stabilization after prior price movements.

Injective reached its all-time high of $52.62 earlier this year, and the current price level reflects a significant retracement from that peak. Market sentiment appears cautious, with short-term indicators showing bearish signals, yet the relatively stable longer-term metrics could suggest a base is forming.

Based on the analysis of technical indicators, including moving averages and RSI levels, along with recent price action, I recommend a Hold rating for INJ at this time. This position allows for monitoring potential recovery signals without committing to a new position until clearer bullish trends emerge.